CMS Entry id: 2709 | Channel: Blog landing page | Template: blog/index

Login
Facebook YouTube Twitter Linkedin
Facebook YouTube Twitter Linkedin

Blog

COVID-19 Cognitive Assessment Battery

To understand the impact of COVID-19 on cognitive function, researchers must use sensitive and reliable cognitive assessments which target appropriate domains. In this article Operational Scientist, Iona Pickett, discusses the challenges of designing a cognitive testing battery for use in those recovering from COVID-19 and describes our recommended CANTAB battery for COVID-19 studies.

Understanding the challenges of assessing cognitive function in patients recovering from COVID-19

While several initiatives have begun investigating the neuropsychological effects of COVID-19, the nature and causes of cognitive impairment found in COVID-19 survivors are not yet fully understood. In this article Operational Scientist, Iona Pickett, discusses the challenges faced by researchers assessing cognition in those recovering from COVID-19.

CANTAB Research Grant assists research into structural and functional changes in memory

We caught up with Julius Rave to talk about the impact that the primary 2021 CANTAB Research Grant prize will have on his research: Exploring structural and functional changes in memory-associated networks in patients expressing cognitive deficits after a COVID-19 infection.

Research into the cognitive impact of COVID-19 on patients with and without sleep complaints

Pim Heckman speaks to us about the impact that receiving one of the three 2021 CANTAB Research Grant prizes will have on his research into clearing COVID-19 cognitive brain fog

Cognitive assessment of COVID-19 patients following mechanical ventilation

Jamileth More recently spoke to us about the impact that receiving one of the three 2021 CANTAB Research Grant prizes will have on her research into monitoring protocol of COVID-19 patients survivors of mechanical ventilation.

CANTAB used to assist with identifying patients with mild cognitive impairment and subjective cognit

Dr. Andrea McGrattan, a Research Dietitian and Lecturer in Nutrition and Dietetics, spoke to us about her PhD research at Queen’s University Belfast, using CANTAB cognitive testing within a Mediterranean Diet feasibility study, “THINK-MED”, among people with cognitive impairment.  

Adherence to a Six-Week Study of Wearable Digital Mood and Cognitive Assessments in Depression

At the 2021 SOBP Annual Meeting, our Director of Research & Innovation, Francesca Cormack hosted an interactive poster session on Adherence to a Six-Week Study of Wearable Digital Mood and Cognitive Assessments in Depression: Qualitative Insight

Read on for the key findings and full poster.

New study uses CANTAB to differentiate typical and pathological ageing

Find out more about how María Campos Magdaleno, PhD of Universidade de Santiago de Compostela is using CANTAB to investigate cognitive changes in typical and pathological ageing.

Cognition and COVID-19: CANTAB Research Grant - Results

The results of the 2021 CANTAB Research Grant are in! This year's award was focussed on the connection between cognition and COVID-19. 

Validation of a Smartphone-based Digit Symbol Substitution Task in Participants With Major Depressio

At the virtual ISCTM - Annual Scientific Meeting, Luke Allen presented data supporting the validity of Smartphone-based DSST for assessments in patient populations such as MDD.

Read on for the key findings and the full poster: Validation and Comparability of Smartphone-based Digit Symbol Substitution Task with Written Version. 

CANTAB and CENTRE-TBI – 10 years working together

CENTRE-TBI recently concluded their 10 year study into the relationship between cognition and function in daily life after traumatic brain injury. We caught up with Prof Lindsay Wilson to hear the key findings from this worldwide study. 

Engagement and Adherence to Remote Testing in Middle-Aged Adults at Risk of Dementia

At the virtual ADPD 2021 event, Emily Thorp discussed engagement and adherence to remote testing in middle-aged adults at risk of dementia.

Experiences of Fatigue in Chronic Disease: Effects on Mental Health

At the recent Chronic Disease & Mental Health virtual event, Iona Pickett discussed experiences of fatigue in chronic disease: effects on mental health. 

Using CANTAB to investigate specific contributions from the volume of hippocampal subregions to visu

We recently caught up with Tamara Shavitt, a psychology student who conducted research at the Faculty of Medicine, University of São Paulo to discuss how CANTAB impacted her research: investigate specific contributions from the volume of hippocampal subregions to visuospatial memory tasks.

Celebrating the women who are working to drive Cambridge Cognition forward – Part 1

To celebrate International Women's Day, we’re sharing the stories of a few of the amazing women we’re proud to say are part of the Cambridge Cognition team. In part 1 we will be speaking to Chief Operating Officer - Fiona Cree, Operational Scientist - Iona Pickett and Director of Statistical Science - Elizabeth Baker.

Celebrating the women who are working to drive Cambridge Cognition forward – Part 2

To celebrate International Women's Day, we’re sharing the stories of a few of the amazing women we’re proud to say are part of the Cambridge Cognition team. In part 2 we will be speaking to our Senior Director of Business Development, Lindsey Hagan, and our Academic Sales Manager, Emma Dominic. 

New study finds CANTAB is sensitive to very early cognitive changes in premanifest Huntington’s dise

Dr. Christelle Langley, postdoctoral Research Associate at the University of Cambridge School of Clinical Medicine shared the role that CANTAB played in her latest publication: Fronto-striatal circuits for cognitive flexibility in far from onset Huntington’s Disease: Evidence from the Young Adult Study

What is the association between anabolic androgenic steroid dependence and executive dysfunction?

We recently spoke with Dr Lisa Evju Hauger to discuss the impact CANTAB had on her research into exploring executive function in relation to long-term anabolic androgenic steroids (AAS) use and dependence.

Cognition and COVID-19 – What we know

Nearly a year on from the first outbreak of COVID-19, we still have a lot to learn about how the virus works and affects our health. In this article Operational Scientist, Iona Pickett, explores our current understanding of the neuropsychological consequences of COVID-19, in particular the impact on cognitive function.

Lessons learned delivering virtual trials during Covid-19

Digital health expert Dr Jordan Brayanov from Takeda Pharmaceuticals shares his lessons learned delivering virtual trials during Covid-19 and predictions on what’s next for the industry.

Using CANTAB to examine the potential synergistic effects of a combination of omega-3 fatty acids, c

Dr Rebecca Power, Postdoctoral Researcher at the Nutrition Research Centre Ireland, shared the role that CANTAB played in her latest publication: Targeted Nutritional Intervention for Patients with Mild Cognitive Impairment: The Cognitive impAiRmEnt Study (CARES) Trial 1

Digital Health Event 2020 | Key takeaways from the industry experts

Industry experts working at the forefront of drug development, devices and digital health shared their lessons learned delivering virtual trials during the Covid-19 pandemic at Cambridge Cognition’s fourth annual Digital Health Event. Catch up on the key takeways from this thought-leading discussion. 

Automated administration of Serial Subtraction in a remote data collection context: novel timing fea

New research presented at CTAD 2020 reports the successful derivation of novel measures of timing for a more nuanced assessment of performance on the Serial Subtraction task. 

Unlocking cognitive research during lockdown: post-webinar Q and A

The volume of discussion and questions during our recent webinar: Remote Cognitive Testing and Lessons Learned During Lockdown was great to see. Unfortunately we were unable to answer all the questions in the time we had so Dr Caroline Skirrow has put together a Q and A addressing some of the key themes raised.  

CANTAB Research Grant assists research into defining cognitive phenotypes

Ciara Molloy recently spoke to us about the impact that receiving one of the three 2020 CANTAB Research Grant prizes will have on her research: ‘The impact of rare copy number variants on cognition: Defining cognitive phenotypes in individuals with CNVs associated with neurodevelopmental and neuropsychiatric disorders.’

2020 CANTAB Research Grant supports research into combined dexmedetomidine / ketamine nasal spray fo

The winner of one of the three 2020 CANTAB Research Grant prizes, Dr Amie Hayley, Swinburne University of Technology explains the impact CANTAB will have on her research: Combined dexmedetomidine/ketamine nasal spray for analgesia: a pilot feasibility and efficacy trial.

CANTAB Research Grant funds new ways to assess vascular cognitive impairment and dementia (VCID) in

Dr Simone De Luca recently received the 2020 CANTAB Research Grant primary award for her project: “New ways to assess vascular cognitive impairment and dementia (VCID) in chronic lung disease”. We spoke to her about the impact winning would have on her research.

Using CANTAB to study the relationships between executive function, eating behavior and preoperative

PhD candidate Gro Walø-Syversen of Oslo University Hospital, shared the role that CANTAB played in her latest publication: Executive Function, Eating Behavior, and Preoperative Weight Loss in Bariatric Surgery Candidates: An Observational Study

Accuracy of automated scoring of verbal paired associates in a remote data collection context

At the virtual AAIC 2020 conference Dr Francesca Cormack shared her research, focusing on automatic speech recognition for verbal cognitive testing. 

Successful delivery of CANTAB cognitive assessments across diverse health systems

At the virtual AAIC 2020 conference Dr Elizabeth Baker presented data on the successful delivery of CANTABTM assessments across diverse health systems and ages: 10 – 90 years old.

The study captures normative performance across the lifespan to support a cognitive screening tool for characterising a range of neuropsychological disorders in clinics across India.